-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-08-24
This scenario-driven guide explains how Cy3 Goat Anti-Mouse IgG (H+L) Antibody, SKU K1207, can improve secondary-antibody detection in cell viability, proliferation, cytotoxicity, immunofluorescence, and flow cytometry workflows. It emphasizes controls, compatibility, titration, storage, and interpretation so fluorescent signal is not mistaken for a direct measure of cell health.
-
12-O-tetradecanoyl phorbol-13-acetate (TPA) Workflows
2026-08-24
Build reproducible ERK/MAPK pathway activation experiments with 12-O-tetradecanoyl phorbol-13-acetate (TPA), from PKC assays to neuronal injury and skin cancer models. The workflow emphasizes time-resolved phospho-ERK measurement, mitochondrial and autophagy readouts, and practical controls that distinguish pathway activation from nonspecific toxicity.
-
(+)-Bicuculline: Practical GABAA Workflow
2026-08-23
This guide explains how to prepare, store, control, and interpret (+)-Bicuculline for experiments requiring competitive GABAA receptor antagonism. It is a neuroscience research tool for controlled in vitro or model-specific in vivo work, not a diagnostic, clinical, or therapeutic product.
-
Substance P: Mechanism, Evidence, and Workflow
2026-08-22
Substance P is an undecapeptide tachykinin neuropeptide that signals primarily through the neurokinin-1 receptor. This article connects its roles in pain transmission research, inflammation, and immune response modulation with evidence-based handling guidance for the B6620 research product.
-
MFGE8 Nanomedicine for Pancreatic Fibrosis
2026-08-22
This study identifies a paracrine antifibrotic mechanism in which umbilical cord mesenchymal stem cell extracellular vesicles deliver MFGE8 to regulate the ANXA1–SMAD2/3 axis in pancreatic stellate cells. It also translates this mechanism into a recombinant MFGE8 nanoparticle platform, linking cell-based therapy, extracellular vesicles, and nanomedicine in chronic pancreatitis models.
-
Cy3 TSA Fluorescence System Kit for Spatial Biology
2026-08-21
The Cy3 TSA Fluorescence System Kit connects ultrasensitive fluorescence microscopy detection with modern spatial-biology questions. This article explains how tyramide deposition, tissue heterogeneity, and proximity-proteomics insights can guide more defensible IHC, ICC, and ISH assay design.
-
L-NMMA acetate: NOS Pathway Research Workflows
2026-08-20
L-NMMA acetate provides a practical way to test whether nitric oxide signaling drives osteogenic, inflammatory, or vascular phenotypes. This guide translates dental follicle cell findings into controlled dose-response workflows, pathway readouts, and troubleshooting decisions.
-
X-Gal and iRhom2: From Clones to Olfactory Biology
2026-08-20
A translational framework for using X-Gal and lacZ reporters to improve construct validation while interpreting iRhom2-dependent olfactory signaling with appropriate mechanistic caution.
-
Coronavirus Macrodomains and PARP-Mediated Antiviral Defense
2026-08-19
The reference study shows that coronavirus macrodomains counter host ADP-ribosylation by preventing PARP-dependent restriction of viral replication and supporting interferon regulation. Pharmacological inhibition and targeted depletion identify PARP12 and PARP14 as important components of this antiviral response, providing a mechanistic framework for studying coronavirus immune evasion.
-
Imipramine: A Causal Autophagy Assay Framework
2026-08-19
Imipramine can support integrated autophagy and apoptosis research, but its value depends on distinguishing pathway modulation from endpoint artifacts. This guide adapts lipidomics-based causal reasoning to glioma, leukemia, neuroscience, and immunology assays without overstating cross-domain evidence.
-
Nutlin-3a and Ferroptosis: A p53 Assay Framework
2026-08-18
Nutlin-3a is a potent MDM2 inhibitor for dissecting p53 pathway activation, cell-cycle control, and apoptosis. This article develops a distinct assay framework that connects MDM2–p53 experiments with the ferroptosis and migration biology described in glioblastoma research.
-
Pexmetinib (ARRY-614) for Cytokine Assays
2026-08-18
Pexmetinib (ARRY-614) gives researchers a practical way to examine inflammatory cytokine inhibition alongside Tie2-linked signaling. This workflow uses concentration bracketing, whole-blood validation, phospho-protein controls, and dephosphorylation assays to distinguish direct pathway modulation from nonspecific toxicity.
-
Direct Mouse Genotyping Kit Plus for SCA3 Models
2026-08-17
Discover how the Direct Mouse Genotyping Kit Plus can strengthen genotype-to-phenotype workflows in SCA3/MJD mouse research. This article connects direct tissue lysate PCR with experimental design, model authentication, and interpretation of neuroinflammation and autophagy findings.
-
Glabridin–Gold(I) Complex Reprograms Tumor Immunity
2026-08-17
The 2025 Advanced Science study develops glabridin–gold(I) complex 6d as an immunomodulatory agent designed to inhibit TrxR and MAPK signaling simultaneously. In liver cancer models, 6d increased dendritic-cell maturation, reduced several immunosuppressive immune populations, lowered tumor-cell PD-L1, and enhanced T-cell granzyme B production, providing a mechanistic rationale for combination immunotherapy studies.
-
Cryptosporidium AdhE: Imidazole Inhibition and Efficacy
2026-08-16
The reference study establishes the bacterial-type bifunctional aldehyde/alcohol dehydrogenase CpAdhE as a chemically tractable target in Cryptosporidium parvum. Screening and follow-up experiments connect lower-micromolar enzyme inhibition by selected antifungal imidazoles with suppression of parasite growth in vitro, while also defining important limits for target validation and therapeutic translation.